Title: Novel Nucleic Acid and Polypeptide Molecules. Number: 20030219739. Filed: Jan. 30, 2002. Lead Inventor: David Glass, Regeneron Pharmaceuticals.

The patent application, its abstract states, covers an invention involving “nucleic acid sequences that encode novel mammalian intracellular signaling polypeptides, designated MURF1, MURF3, or MA-61. The invention also provides assays systems that may be used to detect and/or measure agents that bind the MURF1 or MAFBX gene product.”